U.S. Medical Sterilizers Market - Focused Insights 2023-2028

U.S. MEDICAL STERILIZERS MARKET OVERVIEW

The U.S. medical sterilizers market was valued at $2.13 billion in 2022 and is projected to reach $3.43 billion by 2028, growing at a CAGR of 8.24% from 2022 to 2028.

The unsettling statistics can help us understand the urgency and importance of this market. Nearly 1.7 million hospitalized patients acquire HAIs annually in the U.S. On any given day, 1 in 31 hospitalized patients and 1 in 43 nursing home residents are affected by an HAI. Infections like Central line-associated bloodstream infection (CLABSI) are causing thousands of deaths yearly and draining several million dollars from the U.S. healthcare system.

With direct medical costs of HAIs in U.S. hospitals reaching at least $28,400 million yearly, plus an additional societal burden of $12,400 million from early deaths and lost productivity, the situation demands immediate and effective intervention. The U.S. Department of Health and Human Services (HHS) has recognized the prevention and reduction of HAIs as a top priority, and the correct selection of sterilizers and methods is central to this mission.

Innovative sterilization techniques, such as the use of Nitrogen Dioxide (NO2), are providing efficient solutions. NO2 has been proven as a rapid sterilant, effective against resistant organisms, and suitable for various medical devices. The emergence of accelerator-based radiation sterilization methods and technologies like vaporized Hydrogen Peroxide (H2O2) highlights the relentless innovation in this field.

The acceptance of Polylactic acid (PLA) for implants and the novel sterilization method using supercritical carbon dioxide (scCO2) further illustrates the advancement of the sector and the commitment to green, sustainable technology.

Market leaders like Steris, Getinge, 3M, and Steelco are driving this growth with a range of infection control products, focusing on enhancing hospital productivity, infection control, and innovative technologies.

MEDICAL STERILIZERS MARKET HIGHLIGHTS:

• 1 out of every 31 hospitalized patients and 1 in 43 nursing home residents are affected by an HAI. In addition, the CDC estimates that on any given day, about half of hospital patients are acquiring HAI. Among all the types of infections, Central line-associated bloodstream infection (CLABSI) results in thousands of deaths each year and several million dollars in added costs to the US healthcare system.
• Ethylene oxide sterilization is designed to perform low-temperature, chemical sterilization treatment of medical and pharmaceutical products sensitive to temperature/humidity. As of 2020, the most used sterilants for surface sterilization purposes are ethylene oxide (C2H4O), ozone (O3), chlorine dioxide gas (ClO2), peracetic acid (CH3CO3H), and hydrogen peroxide (H2O2)
• As of 2020, the most used sterilants for surface sterilization purposes are ethylene oxide (C2H4O), ozone (O3), chlorine dioxide gas (ClO2), peracetic acid (CH3CO3H), and hydrogen peroxide (H2O2)
• Thermal sterilization is the oldest, most easily available, and most widely used sterilization method in the world. An autoclave is a widely used method for moist heat sterilization.
• Large sterilizers do come with an advanced software and hardware-based monitoring system. This feature allows unattended operation without sacrificing reliability or safety.